NCT05742295View on ClinicalTrials.gov

Prevention of Cefoperazone-induced Coagulopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 25, 2023

Primary Completion Date

October 5, 2023

Study Completion Date

October 5, 2023

Conditions
Antibiotic Side Effect
Interventions
DRUG

Vitamin K

Coadministration of vitamin K with the first dose of cefoperazone/sulbactam

Trial Locations (1)

Unknown

6-October Hospital, Giza

All Listed Sponsors
lead

Helwan University

OTHER

NCT05742295 - Prevention of Cefoperazone-induced Coagulopathy | Biotech Hunter | Biotech Hunter